Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
The ESC chooses renowned scientists who, through original contributions and qualified investigation, are accepted by their peers as leading experts in their fields of knowledge.
They cover the areas of Clinical Cardiology, Interventional cardiology, Population Science and Basic Science.
ESC Geoffrey Rose Lecture on Population Sciences
Prevention of stroke in atrial fibrillation: 3 decades of progress - Where next?
Stuart Connolly is an Emeritus Professor of Medicine at McMaster University and cardiologist at Hamilton Health Sciences in Hamilton Ontario Canada. He has a Masters in philosophy from Fordham University and an MD from McGill University in Montreal. He received his specialist training in Cardiology at the University of Toronto and Stanford University.
Dr. Connolly is recognized internationally for his research specialising in the evaluation of treatments for heart rhythm disorders and prevention of stroke, particularly by means of large global randomised controlled trials. He has published more than 335 scientific articles over his career, including more than 30 articles in the New England Journal of Medicine.
ESC Andreas Grüntzig Lecture on Interventional Cardiology
The interventional paradox: when more is more and when less is more
Martin B. Leon, MD, is a Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy (CIVT) at NewYork-Presbyterian Hospital/Columbia University Medical Center. Previously, Dr. Leon was also the Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian Hospital/Columbia University Medical Center and currently he serves on the Executive Board of the NewYork-Presbyterian/Columbia Heart Valve Center. Dr. Leon was the Founder of Transcatheter Cardiovascular Therapeutics (TCT) symposium and Chairman Emeritus of the Cardiovascular Research Foundation (CRF) in New York City and is currently CRF’s Co-Director, Medical Research and Education Division. TCT is the largest dedicated interventional cardiology meeting in the world and CRF is the largest independent not-for-profit cardiovascular research center in the world.
A distinguished pioneer in interventional cardiovascular medicine, Dr. Leon has been the national principal investigator for over 50 clinical trials that have helped shape the field including STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, RESOLUTE, and most recently, the PARTNER trials, studying the value of transcatheter valve therapy for patients with aortic stenosis. He has co-authored almost 2,000 peer reviewed scientific publications and abstracts, which have appeared in the most prestigious medical journals. As a practicing interventional cardiologist, Dr. Leon has performed over 10,000 procedures during his career.
He is the Founder and Director of Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier scientific symposium dedicated to interventional cardiovascular medicine, which is celebrating its 30th anniversary this year. He has also been the Director or Co-Director of more than 100 international educational programs in the field. Dr. Leon has received 20 international career achievement awards and was awarded an honorary degree from the University of Athens.
Dr. Leon was previously the Director of Cardiovascular Research and Education at the Lenox Hill Heart and Vascular Institute in New York as well as Director of Clinical Research at the Washington Cardiology Center at the Washington Hospital Center and Clinical Professor of Medicine at Georgetown University Medical Center in Washington, DC. He also served as a Clinical Associate, Senior Investigator, and Director of the Catheterization Laboratories in the Cardiology Branch of the National Heart, Lung and Blood Institute at the National Institutes of Health in Bethesda, Maryland. He was a founder of the Washington Cardiology Center and the Cardiology Research Foundation in Washington, DC.
Dr. Leon received his medical degree from the Yale School of Medicine and completed his internal medicine internship and residency as well as a cardiology fellowship at the Yale-New Haven Hospital.
ESC Paul Hugenholtz lecture for innovation - Read more
Innovation in CV Medicine: Together we win
Francesco Maisano is the head of the Heart Center and Chair of Cardiovascular Surgery at University Hospital of Zurich. He is a cardiac surgeon with large experience in standard cardiovascular treatments and innovative technologies, as well as cross-trained in interventional cardiology, with specific focus on structural interventions.
He covers different international academic and scientific advisory roles, membership in professional associations, review and editorial boards activities. His main area of interest is structural heart disease, ranging from surgical to catheter-based therapies, with experience in the implementation of innovative therapies in clinical practice, focusing on training and education.
As inventor and innovator, he has filed more than 20 patents, and founded multiple start-up companies in the field of cardiovascular medicine. He has collaborated with multiple industry partners to contribute to the research and development of a number of surgical and interventional devices currently available for clinical use.
ESC Rene Laennec Lecture on Clinical Cardiology
Cardiovascular imaging for the future: it’s chalk and cheese
David Newby is British Heart Foundation John Wheatley Chair of Cardiology at the University of Edinburgh. He is Director of Edinburgh Clinical Research and Imaging Facilities and a Consultant Interventional Cardiologist at Royal Infirmary of Edinburgh. He has major interests in experimental medicine and the advanced imaging of cardiovascular disease including coronary heart disease, aortic stenosis and heart failure. He has been involved in several multicentre trials and has played a major role in the conduct of the SALTIRE (British Heart Foundation funded Scottish Aortic stenosis Lipid lowering Trial, Impact on REgression) and 3CPO (Health Technology Assessment trial of non-invasive ventilation for acute cardiogenic pulmonary oedema) trials. He is Chief Investigator for the SCOT-HEART trial funded by the Chief Scientist Office; a national multicentre randomised controlled trial of computed tomography coronary angiography. He has recently developed the use of positron emission tomography in a range of cardiovascular diseases.
ESC William Harvey Lecture on Basic Science
Genetic engineering to mend the Heart
Professor Priori received her Degree in Medicine in 1985 at Milan University, her specialization in Cardiology in 1989 at Milan University and her PhD in Cardiovascular Pathophysiology at Milan University. She is Global Scientific Director of Istituti Clinici Scientifici Maugeri (ICS MAUGERI) SpA SB, Full Professor of Cardiology since 2014 in the Department of Molecular Medicine at the University of Pavia (Italy), Director of the Molecular Cardiology Unit at the Centro National de Investigaciones Cardiovasculares Carlos III (CNIC) Madrid Spain and at the ICS MAUGERI in Pavia, Italy. She is best known for her work on genetics and pathophysiology of genetic cardiac arrhythmias and, in the last years, for Genetic Therapy of these diseases. The translational research conducted in her laboratories ranges from molecular studies in induced-pluripotent stem cells derived myocytes used as a disease model to functional investigations in transgenic animals and to the development of gene therapies. On the clinical and several landmark studies in the field of inherited arrhythmias have identified novel therapies, developed risk stratification schemes and contributed to the definition of clinical management for patients with inherited arrhythmias.
The Named lectures take place in the corresponding villages on Sunday 27 August. This year the Named Lecture is followed by the Young Investigator Awards session on the same topic.
08:30 ESC Geoffrey Rose Lecture on Population Sciences
Can we eradicate premature cardiovascular deaths?
Simon trained in general, respiratory and cardiovascular medicine in Newcastle, Edinburgh, Cardiff, and Oxford. He was appointed as the first Professor of Clinical Epidemiology in the University of Liverpool in 1999.
Simon enjoys facilitating multidisciplinary research teams, mentoring colleagues and writing papers and grant applications. He manages a research programme mainly involving cardiovascular disease (CVD) and food policy, with well over three hundred publications and funding thus far totalling over £25 million from EU, NIH, BHF, MRC & NIHR. Simon is Vice President (Policy) for the UK Faculty of Public Health, previous President of the Society for Social Medicine and a Trustee for the FPH, for the UK Health Forum, and for Heart of Mersey.
He has recently chaired/participated in a dozen national /international policy and prevention committees, including Academy of Medical Royal Colleges (Obesity), Obesity Health Alliance, NICE, American Heart Association, European Society of Cardiology and WHO.
14:00 ESC William Harvey Lecture on Basic Science PCSK9: a journey of discovery from genetics to clinical trials
Professor Catherine Boileau is current Head of the Genetics Department at Bichat University Hospital in Paris, and Professor of Medical Genetics at University Paris Diderot. She is also Director of Research of the Northern Paris University hospitals (AP-HP). She has headed INSERM research teams since 1994. Presently she co-heads the “Structural cardiovascular diseases” Team at INSERM U1148 (Laboratory for Vascular Translational Science). Her research interests focus on identifying the genetic component of vascular diseases, through the identification of disease genes, susceptibility factors and modifier genes in two models of inherited diseases: familial hypercholesterolemia and inherited thoracic aortic aneurysm and dissection.
Professor Boileau has authored more than 300 articles in peer-reviewed international journals. Professor Boileau headed for 5 years the Scientific Advisory Board of the French Rare Diseases Foundation and is an active member of the French National Atherosclerosis Society, the European and American societies of Human Genetics and Cardiology. She is also a member of the Directoire (Governing board) and the CME (Medical Board) of the Paris University Hospitals (AP-HP).
14:00 ESC Andreas Grüntzig Lecture on Interventional Cardiology The revolution in the treatment of patients with aortic stenosis
Dr Morice is an interventional cardiologist with more than 30 years of experience as Head of the highest-volume PCI centers in the Greater Paris Area (CCN, ICPS). A fellow of the ESC and the ACC, Honorary Professor of the Universidad Del Salvador in Buenos Aires and a Senior Consulting Adviser to EuroPCR, she is a guest lecturer and chairperson at all major international Cardiology scientific sessions. Dr Morice has been involved in multiple landmark research trials such as RAVEL and SYNTAX as a Primary Investigator and has published more than 300 peer-reviewed articles. She is the President and Medical Director of the European Center for Cardiovascular Research (CERC). In 2013, Dr Morice was designated Best Interventional Cardiologist in France and in 2014 she received the CHIEN award during ASIA PCR and the Geoffrey O. Hartzler Master Operator Award at TCT 2014 for her career achievements.
14:00 ESC Rene Laennec Lecture on Clinical Cardiology Adipose tissue and myocardial ageing
More on the named lectures
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved